Programmable cellular protein factories
Science · 16.04.2026 · 392 (6795) · 252-253
DOI: 10.1126/science.aeg7084 ↗Kurz gefasst
Kommentar in der Zeitschrift Science, erschienen am 16.04.2026. Verfasst von Richard G James und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity and Immunotherapies , Seattle Children's Research Institute, Seattle, WA, USA. Hauptthemen laut MEDLINE: Antibodies, Cell Engineering, Precursor Cells, B-Lymphoid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Engineered immune cell precursors produce antibodies on demand in mice
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Immunity and Immunotherapies , Seattle Children's Research Institute, Seattle, WA, USA.
- Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Zitieren
APA
James, R. G., & Zhang, T. T. (2026). Programmable cellular protein factories. Science, 392(6795), 252-253. https://doi.org/10.1126/science.aeg7084
Vancouver
James RG, Zhang TT. Programmable cellular protein factories. Science. 2026;392(6795):252-253. doi:10.1126/science.aeg7084
BibTeX
@article{James2026,
author = {James, Richard G and Zhang, Ting-Ting},
title = {Programmable cellular protein factories},
journal = {Science},
year = {2026},
volume = {392},
number = {6795},
pages = {252--253},
doi = {10.1126/science.aeg7084}
}
EUVIMED